Table 2.
Grade ≥ 3 Toxicities Generally Associated With Bevacizumab During the 9-Month Period Beginning 3 Months After Completion of All Therapy
| Toxicity | mFF6 | mFF6+Bev |
|---|---|---|
| Hypertension | 0.6 | 0.7 |
| Pain | 1.1 | 1.1 |
| Proteinuria | 0.1 | 0 |
| ATE | 0.1 | 0.5 |
| VTE | 0.4 | 0.2 |
| Hemorrhage | 0.3 | 0.3 |
Abbreviations: ATE, arterial thrombotic event; mFF6, modified fluorouracil, leucovorin, and oxaliplatin for 6 months; mFF6 + Bev, mFF6 for 6 months plus bevacizumab for 12 months; VTE, venous thrombotic event.